Boon For Lupin As FDA Upgrades Somerset Site Status

Stricken US Facility Handed Voluntary Action Indicated Status By FDA

 
• By Dean Rudge
  
manufacturing facility
Lupin must return its facilities to FDA compliance • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Business